Lithuania’s Biomatter raises $18M for AI enzyme design
Vilnius-based Biomatter has raised $18M in a Series A round to scale its AI enzyme design platform. Astanor led the oversubscribed round. Existing investors UVC Partners, Inventure and Metaplanet also took part. The company announced the round in a press…
Adjust this page to suit you. Your choices are saved in this browser.
Cookies. Chipokia uses one cookie, and only if you allow it: a random ID so your up and down votes stay yours. No analytics, no advertising, no tracking of any kind. Privacy & Cookie Policy.
